Back to Search
VENKATARAMAN KALYANARAMAN, MD
MD
Endocrinology, Diabetes & Metabolism Physician
NPI: 1598813016Individual
Specialties, Licenses & Credentials
Endocrinology, Diabetes & Metabolism PhysicianPrimary
Internal Medicine — Endocrinology, Diabetes & Metabolism
Code: 207RE0101X
20440(OK)
Research & Publications (20)
Correlation of vaccine-elicited systemic and mucosal nonneutralizing antibody activities with reduced acute viremia following intrarectal simian immunodeficiency virus SIVmac251 challenge of rhesus macaques.
PMID 18971271·J Virol·2009
7-preclinical
Difficulties in monitoring the glucose status of patients undergoing hematopoietic stem cell transplantation.
PMID 19589491·Biol Blood Marrow Transplant·2009
2-rct
Replicating adenovirus HIV/SIV recombinant priming alone or in combination with a gp140 protein boost results in significant control of viremia following a SHIV89.6P challenge in Mamu-A*01 negative rhesus macaques.
PMID 18252262·Virology·2008
7-preclinical
Comparative study of Tat vaccine regimens in Mauritian cynomolgus and Indian rhesus macaques: influence of Mauritian MHC haplotypes on susceptibility/resistance to SHIV(89.6P) infection.
PMID 18486283·Vaccine·2008
7-preclinical
A comprehensive analysis of the naturally occurring polymorphisms in HIV-1 Vpr: potential impact on CTL epitopes.
PMID 18721481·Virol J·2008
8-other
Sequential priming with simian immunodeficiency virus (SIV) DNA vaccines, with or without encoded cytokines, and a replicating adenovirus-SIV recombinant followed by protein boosting does not control a pathogenic SIVmac251 mucosal challenge.
PMID 18753198·J Virol·2008
7-preclinical
Comparative evaluation of oral and intranasal priming with replication-competent adenovirus 5 host range mutant (Ad5hr)-simian immunodeficiency virus (SIV) recombinant vaccines on immunogenicity and protective efficacy against SIV(mac251).
PMID 17935840·Vaccine·2007
4-observational
A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques.
PMID 17229693·J Virol·2007
7-preclinical
HIV-1 prophylactic vaccine comprised of topical DermaVir prime and protein boost elicits cellular immune responses and controls pathogenic R5 SHIV162P3.
PMID 17499328·Virology·2007
7-preclinical
Shuttling of G protein subunits between the plasma membrane and intracellular membranes.
PMID 17576765·J Biol Chem·2007
7-preclinical
A family of G protein βγ subunits translocate reversibly from the plasma membrane to endomembranes on receptor activation.
PMID 17581822·J Biol Chem·2007
7-preclinical
Coadsorption of HIV-1 p24 and gp120 proteins to surfactant-free anionic PLA nanoparticles preserves antigenicity and immunogenicity.
PMID 16919350·J Control Release·2006
7-preclinical
An adenovirus-based HIV subtype B prime/boost vaccine regimen elicits antibodies mediating broad antibody-dependent cellular cytotoxicity against non-subtype B HIV strains.
PMID 16940858·J Acquir Immune Defic Syndr·2006
7-preclinical
G protein betagamma complex translocation from plasma membrane to Golgi complex is influenced by receptor gamma subunit interaction.
PMID 16517125·Cell Signal·2006
7-preclinical
Systemic immunization with an ALVAC-HIV-1/protein boost vaccine strategy protects rhesus macaques from CD4+ T-cell loss and reduces both systemic and mucosal simian-human immunodeficiency virus SHIVKU2 RNA levels.
PMID 16571790·J Virol·2006
7-preclinical
Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E.
PMID 16616287·Virology·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 920 STANTON L YOUNG BLVD # 1345
OKLAHOMA CITY, OK 73104 - Phone
- (405) 271-5896
Quick Facts
- NPI
- 1598813016
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile